Cresco Labs Inc (CRLBF)
1.092
-0.06
(-5.00%)
USD |
OTCM |
Nov 22, 16:00
Cresco Labs Debt to Equity Ratio: 1.136 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.136 |
| June 30, 2024 | 1.093 |
| March 31, 2024 | 1.032 |
| December 31, 2023 | 1.004 |
| September 30, 2023 | 1.024 |
| June 30, 2023 | 0.7858 |
| March 31, 2023 | 0.803 |
| December 31, 2022 | 0.7757 |
| September 30, 2022 | 0.6175 |
| June 30, 2022 | 0.6084 |
| March 31, 2022 | 0.6816 |
| December 31, 2021 | 0.6284 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.715 |
| June 30, 2021 | 0.3311 |
| March 31, 2021 | 0.4676 |
| December 31, 2020 | 0.5945 |
| September 30, 2020 | 0.1943 |
| June 30, 2020 | 0.2008 |
| March 31, 2020 | 0.1907 |
| December 31, 2019 | 0.0029 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.0001 |
| March 31, 2019 | 0.0029 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0029
Minimum
Dec 2019
1.136
Maximum
Sep 2024
0.6443
Average
0.655
Median
Debt to Equity Ratio Benchmarks
| MariMed Inc | 1.085 |
| cbdMD Inc | 0.4551 |
| Flora Growth Corp | 0.5259 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.383B |
| Total Liabilities (Quarterly) | 1.018B |
| Shareholders Equity (Quarterly) | 456.88M |
| Current Ratio | 1.967 |
| Net Debt Paydown Yield | -1.01% |